These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21575708)
1. Possible mechanism of perfluorooctane sulfonate and perfluorooctanoate on the release of calcium ion from calcium stores in primary cultures of rat hippocampal neurons. Liu X; Jin Y; Liu W; Wang F; Hao S Toxicol In Vitro; 2011 Oct; 25(7):1294-301. PubMed ID: 21575708 [TBL] [Abstract][Full Text] [Related]
2. Effects of subchronic perfluorooctane sulfonate exposure of rats on calcium-dependent signaling molecules in the brain tissue. Liu X; Liu W; Jin Y; Yu W; Liu L; Yu H Arch Toxicol; 2010 Jun; 84(6):471-9. PubMed ID: 20127074 [TBL] [Abstract][Full Text] [Related]
3. Perfluorooctane sulfonate induces neuronal and oligodendrocytic differentiation in neural stem cells and alters the expression of PPARγ in vitro and in vivo. Wan Ibrahim WN; Tofighi R; Onishchenko N; Rebellato P; Bose R; Uhlén P; Ceccatelli S Toxicol Appl Pharmacol; 2013 May; 269(1):51-60. PubMed ID: 23500012 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells. Shan G; Ye M; Zhu B; Zhu L Chemosphere; 2013 Nov; 93(9):2101-7. PubMed ID: 23972907 [TBL] [Abstract][Full Text] [Related]
5. In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice. Ngo HT; Hetland RB; Sabaredzovic A; Haug LS; Steffensen IL Environ Res; 2014 Jul; 132():251-63. PubMed ID: 24834819 [TBL] [Abstract][Full Text] [Related]
7. Acute enhancement of synaptic transmission and chronic inhibition of synaptogenesis induced by perfluorooctane sulfonate through mediation of voltage-dependent calcium channel. Liao CY; Li XY; Wu B; Duan S; Jiang GB Environ Sci Technol; 2008 Jul; 42(14):5335-41. PubMed ID: 18754390 [TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of perfluorooctane sulfonate (PFOS) in rats and mice after single oral exposure. Sato I; Kawamoto K; Nishikawa Y; Tsuda S; Yoshida M; Yaegashi K; Saito N; Liu W; Jin Y J Toxicol Sci; 2009 Oct; 34(5):569-74. PubMed ID: 19797866 [TBL] [Abstract][Full Text] [Related]
9. Neonatal and juvenile exposure to perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS): Advance puberty onset and kisspeptin system disturbance in female rats. Du G; Hu J; Huang Z; Yu M; Lu C; Wang X; Wu D Ecotoxicol Environ Saf; 2019 Jan; 167():412-421. PubMed ID: 30368134 [TBL] [Abstract][Full Text] [Related]
11. Role of astrocytes-derived d-serine in PFOS-induced neurotoxicity through NMDARs in the rat primary hippocampal neurons. Wang R; Wang R; Niu X; Cheng Y; Shang X; Li Y; Li S; Liu X; Shao J Toxicology; 2019 Jun; 422():14-24. PubMed ID: 31004706 [TBL] [Abstract][Full Text] [Related]
12. [Researching progresses in environmental pollution behavior, toxic effects and mechanisms of PFOS/PFOA]. Zhou QX; Hu XG Huan Jing Ke Xue; 2007 Oct; 28(10):2153-62. PubMed ID: 18268971 [TBL] [Abstract][Full Text] [Related]
13. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Takacs ML; Abbott BD Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030 [TBL] [Abstract][Full Text] [Related]
14. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Bjork JA; Butenhoff JL; Wallace KB Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365 [TBL] [Abstract][Full Text] [Related]
15. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093 [TBL] [Abstract][Full Text] [Related]
16. Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS). Franco ME; Sutherland GE; Fernandez-Luna MT; Lavado R Toxicology; 2020 Jan; 430():152339. PubMed ID: 31809754 [TBL] [Abstract][Full Text] [Related]
17. Effects of perfluorooctane sulfonate on tracheal ciliary beating frequency in mice. Matsubara E; Nakahari T; Yoshida H; Kuroiwa T; Harada KH; Inoue K; Koizumi A Toxicology; 2007 Jul; 236(3):190-8. PubMed ID: 17544559 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Corsini E; Avogadro A; Galbiati V; dell'Agli M; Marinovich M; Galli CL; Germolec DR Toxicol Appl Pharmacol; 2011 Jan; 250(2):108-16. PubMed ID: 21075133 [TBL] [Abstract][Full Text] [Related]
19. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Nakayama S; Harada K; Inoue K; Sasaki K; Seery B; Saito N; Koizumi A Environ Sci; 2005; 12(6):293-313. PubMed ID: 16609670 [TBL] [Abstract][Full Text] [Related]
20. Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Hu XZ; Hu DC Arch Toxicol; 2009 Sep; 83(9):851-61. PubMed ID: 19468714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]